- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Panel Discussion: Defining Quality in Oncology: Is There a Common Ground?
Although there have been some accusations of "cookbook medicine" with regards to measurement guidelines, panelists Dennis Scanlon, PhD, Jess DeMartino, PhD, Phyllis Torda, and Laura Long, MD, do see progress to remedy the situation and make guidelines more effective.
%jwplayer%
Although there have been some accusations of “cookbook medicine” with regards to measurement guidelines, panelists Dennis Scanlon, PhD, Jess DeMartino, PhD, Phyllis Torda, and Laura Long, MD, do see progress to remedy the situation and make guidelines more effective.
Part of the problem is in the measurement itself, according to Dr Scanlon, who recommends going back to the reason why the industry measures in the first place, such as for accountability, quality improvement, surveillance and payment purposes.
Dr Long added that guidelines should not just be for evidence-based care or efficacy but what is important to patients. The National Comprehensive Cancer Network, where Dr DeMartino works, aims to educate patients with their own set of guidelines that include glossary terms to explain concepts like deductibles and co-pays.
Ms Torda added that active promotion of patient involvement is becoming more common and patients are being engaged in 3 ways: directly in the delivery of their care; through advisory boards within practices; and with advocacy on the policy level.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
